Opioid-induced hyperalgesia
Opioid-induced hyperalgesia (OIH) is a medical condition characterized by an increased sensitivity to pain resulting from the prolonged use of opioids. This phenomenon is distinct from tolerance, where the effect of a drug diminishes over time, and physical dependence, where withdrawal symptoms occur when a drug is abruptly discontinued.
Etiology[edit]
The exact cause of OIH is not fully understood. However, it is believed to be related to the long-term exposure of the nervous system to opioids, which can alter the functioning of pain pathways and increase sensitivity to painful stimuli. This can result in a paradoxical response where the individual experiences increased pain despite increasing doses of opioids.
Clinical Presentation[edit]
Patients with OIH often present with a diffuse, non-localizable, and fluctuating pain pattern that is out of proportion to the identified pathology. The pain often extends beyond the original pain site and can be accompanied by abnormal pain behaviors and a decreased functional status.
Diagnosis[edit]
Diagnosis of OIH can be challenging due to its overlap with other conditions such as tolerance and opioid withdrawal. A high index of suspicion is required, especially in patients who have escalating opioid requirements without a clear cause.
Treatment[edit]
Treatment strategies for OIH include reducing or discontinuing the opioid, rotating to a different opioid, or adding a non-opioid analgesic. In some cases, NMDA receptor antagonists such as ketamine or dextromethorphan may be used.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
